CD274 and cancer: Remarkably, compared with fm-PD-L1-Lytaca, nf-PD-L1-Lytaca exhibited significantly enhanced degradation efficiency in macrophages (Fig. 5g) and cancer cells (Supplementary Fig. 18a, b).